Search results
Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea
Eyewitness News 3 Hartford· 4 days agoTirzepatide, the medication in the weight-loss drug Zepbound and also the diabetes treatment...
Obesity drugs from Altimmune, Hengrui show potential; Lilly details Zepbound sleep apnea data
BioPharma Dive via Yahoo Finance· 23 hours agoA fuller presentation of results at the ADA meeting, also published in The New England Journal of...
ResMed Stock Dives. Blame Eli Lilly’s Zepbound Trials for Sleep Apnea.
Barrons.com· 18 hours agoStrong results from Eli Lilly’s obesity medicine in a sleep apnea trial could upset the sleep apnea...
What's the Best Pillow Setup for Sleep?
Time via AOL· 16 hours agoSnoring is often a sign of obstructive sleep apnea, a condition in which the airway becomes blocked and our breathing pauses. Sleep apnea should be...
ADA 2024: Altimmune’s GLP-1 drug shows weight loss potential
Clinical Trials Arena via Yahoo Finance· 3 hours agoAlongside Altimmune’s announcement, companies such as Novo Nordisk...positive results from the...
Tirzepatide Significantly Reduces Sleep Disruptions
Medscape· 3 days agoThe diabetes and weight loss drug tirzepatide (Mounjaro for type 2 diabetes; Zepbound for obesity) was so effective at reducing sleep disruptions in...
Tirzepatide May Help Treat Sleep Apnea in People With Obesity
MedPage Today· 4 days agoTirzepatide (Zepbound) improved symptoms of moderate-to-severe obstructive sleep apnea (OSA) in...
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
Investor's Business Daily· 15 hours agoResMed and Inspire Medical Systems stocks tumbled Monday after Eli Lilly said its weight-loss drug...
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters via Yahoo News· 4 days agoEli Lilly on Friday said its popular weight-loss drug Zepbound helped resolve moderate to severe...
Eli Lilly seeks FDA’s OK to expand Zepbound’s uses to include sleep apnea
Market Watch· 4 days agoThe antiobesity medication sharply reduced the restriction or blocking of airflow in patients with ...
